Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150038/S044

Exablate Model 4000 System

Insightec · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONP150038/S044

What did the FDA approve?

The FDA record P150038/S044, dated 2026-09-16, is an approval of a normal 180-day-track supplement without user fee for the Exablate Model 4000 System, a magnetic-resonance-guided focused ultrasound device under product code POH (Neurology), submitted by Insightec. The supplement's stated reason is a location change covering manufacturer, sterilizer, packager or supplier, and its statement concerns a manufacturing site at Molded Rubber and Plastics Corporation, 13161 W. Glendale Avenue, Butler, WI 53007, USA.

That new Wisconsin location is described as an additional manufacturing site for the Exablate 4000 Treatment Kits. The supplement number identifies it as a change to the original P150038 approval rather than an original PMA, and approving a site is not an approval of the whole system or an independent finding of safety or clinical effectiveness; the record supplies no detail on qualification, inspection or validation of the site, the materials handled there, or any clinical or labeling consequences.

Specific information absent from the supplied fields includes what the kits contain, what operations occur at Butler, and whether the existing manufacturing site or sites remain unchanged.

FDA approval order statement

approval for a manufacturing site located at Molded Rubber and Plastics Corporation, 13161 W. Glendale Avenue, Butler, WI 53007, USA. This new site will be an additional manufacturing site for the Exablate 4000 Treatment Kits.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Neurology
Decision date
Sep 16, 2026
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P150038/S044
Regulatory pathway
PMA supplement
Applicant
Insightec
Product code
POH
Decision code
APPR
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: MR-guided focused ultrasound system.

Applicant
Insightec
Product code
POH
FDA device class
3

For the original device and its historical approval scope, see PMA P150038. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150038/S043 · Related supplement

    Exablate Model 4000 System

  2. P150038/S042 · Related supplement

    Exablate Model 4000 Type 1.0 and 1.1 (Exablate Neuro; Exablate Prime)

  3. P150038/S044 received

    Application receipt date recorded by FDA.

  4. P150038/S044 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P150038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150038

Product / regulatory recordCompanyPathwayDecision dateSource
EXABLATEP150038
InsightecPMA approvalJul 11, 2016FDA
InsightecPMA supplementJan 28, 2026FDA
InsightecPMA supplementMar 5, 2026FDA
EXABLATEP150038/S041
InsightecPMA supplementMar 23, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Insightec

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5 Nahum Heth St., Tirat Carmel, 39120

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records